The first results of the research for patients of the Eastern region with Alopecia areata (AA) were presented by the One Health Company at The EADV. The researchers have set themselves the targets to collect epidemiological, anamnestic, clinical and psychosomatic data in AA Eastern patients. Furthermore, they pointed out the importance of one international registry of patients, that may help to share and compile the information, evaluate effectiveness and safety of the most advanced treatments for AA.
